What are the options for patients without insurance coverage?
Myriad recognizes that early reimbursement may be uncertain as the test’s value and payer acceptance is being developed in the marketplace. For a limited time, Myriad will be offering the OnDose Patient Protection Program (after the patient’s deductible has been met). This program is designed to protect patients undergoing infusional 5-FU chemotherapy from unexpected financial liability due to limited insurance coverage during the introduction of OnDose. For qualified OnDose patients, out-of-pocket costs will be limited to 20% of the billed charges from Myriad after the patient’s deductible has been met. This equates to a maximum of $60 per test for patients enrolled in the Patient Protection Program. Patients can enroll in the Patient Protection Program by calling the toll-free number located on the Myriad invoice. The Patient Protection Program is not available to patients covered under Medicare, Medicaid, or other government programs, or those who reside in Florida, Massachusetts, T
